A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

Completed · Phase 1

Conditions studied: Obstetric Labour, Premature, Premature Ejaculation

In brief

A study conducted on healthy volunteers to determine the safety, tolerability and affect on the human body by experimental drug GSK557296.

Key facts

Study ID

NCT00549211

Run by

GlaxoSmithKline

People needed

42

Starts

2007-10-01

Last updated by the study team

2012-03-19

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy males who are 18 to 45 years of age
• Body mass index between 19 and 30 with a body weight greater than 110 pounds and deemed healthy by a physician
• Non-smokers

You may not qualify if…

• Alcohol consumption averaging more than 7 drinks per week
• Positive for Hepatitis C antibody, Hepatitis B antigen or HIV
• Any use of prescription drugs or non prescription drugs

Where it is running

• GSK Investigational Site — Evansville, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.